Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00064116
Recruitment Status : Completed
First Posted : July 9, 2003
Last Update Posted : June 24, 2014
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )